Refine by
Applications
- Actionable Molecular Diagnostic System for Physicians
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Exactvu - The Practical Solution for Targeted Biopsies
- ExactVu - Micro-Ultrasound System for Transrectal Targeted Biopsy
- ExactVu - Micro-Ultrasound System for Transperineal Targeted Biopsies
- Fusion - Bx - Semi-Robotic Arm System for Physicians
- Fusion - Bx - Semi-Robotic Arm System for Patients
Prostatic Equipment & Supplies In Iran
178 equipment items found
Manufactured by:UroLift System based inPleasanton, CALIFORNIA (USA)
UroLift Implant: the obstructing prostatic lobes are held apart by small permanent UroLift Implants that are deployed by the delivery device. Each implant is made with common implantable materials: nitinol, stainless steel, and PET suture. Typically, four implants are placed into the ...
Manufactured by:ProUroCare Medical Inc. based inEden Prairie, MINNESOTA (USA)
ProUroScan is an advanced medical imaging system that uses an array of sensors mounted on a rectal probe, a central processing unit and software and image construction algorithms to provide a real time color image of abnormalities in the ...
Manufactured by:Futura System Group S.r.l. based inFormello (Roma), ITALY
Increasing kinetic colorimetric method according to Hillmann. Prefilled Buffer in 2 mL vials, Tartrate reagent liquid and ready to use, Substrate Fast Red as tablets to dissolve in the Buffer. Working Solution stability of 2 days at 2-8° C. Specific for serum (avoid ...
Manufactured by:Best NOMOS based inPittsburgh, PENNSYLVANIA (USA)
Fast, simple and precise prostate brachytherapy. Safe stabilization and precise seed ...
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black Box” warnings. ...
by:Pars Isotope Co based inTehran, IRAN
The PARS-LUTOPSMA kit is an innovative theranostic radiopharmaceutical developed by Parsisotope Company, designed specifically for the treatment of metastatic prostate cancer. This kit is notable for being the first of its kind globally, and is used in conjunction with the Lu-177 radioisotope. It targets prostate-specific membrane antigen (PSMA), a membrane ...
Manufactured by:Allium Ltd based in, ISRAEL
Allium’s unique large caliber, site-specific, triangular shaped, dynamic and easily removable prostatic stent implant, is uniquely designed to provide a long term, reversible solution for a period of up to 3 years. Allium’s unique prostatic stent implant have a large caliber triangular cross-section to match the contours of an enlarged male ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
A Prostate-Specific Membrane Antigen (PSMA) imaging agent for the detection & staging of prostate ...
Manufactured by:Ferring Pharmaceuticals based inSaint-Prex, SWITZERLAND
FIRMAGON® (degarelix) is a treatment for men with advanced hormone-dependent prostate cancer. It has a novel mechanism of action that is different from traditional LHRH agonist therapy commonly used. Decreasing testosterone levels can cause the cancer cells to die, thus reducing the size of the tumour and delaying its growth. ...
Manufactured by:Calbiotech Inc. based inEl Cajon, CALIFORNIA (USA)
Catalog number: PS235T. Product type: ELISA. Quantity: 96 Tests (12x8 breakable strip wells). Standard range: 2-50 ng/ml. Analytical Sensitivity: 2 ng/ml. Sample volume: 25 µl/well. Species: Human. Storage and Stability: Product should be stored at 2-8 °C. Precautions: For research use only. Not for use in diagnostic procedures. ...
by:Pars Isotope Co based inTehran, IRAN
Lu-177-PSMA is a theranostic radiopharmaceutical designed for the treatment of metastatic prostate cancer. Employing the Peptide Receptor Radionuclide Therapy (PRRT) technique, it selectively targets and binds to prostate tumor cells, facilitating the destruction of malignant cells. This unique action stems from its characteristic as a gamma emitter, allowing not ...
Manufactured by:Nanostics Inc. based inEdmonton, ALBERTA (CANADA)
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare decisions. Validation of ClarityDX Prostate® is ongoing in a 2800 patient clinical study designed to meet regulatory ...
Manufactured by:EDAP TMS based inVaulx-en-Velin, FRANCE
Focal treatment strategy for Prostate Cancer (PCa) is playing a growing role in today's surgical practice. By combining the latest imaging and treatment technologies, Focal One® brings the answer to current requirements for ideal focal therapy: accurate and MR-fused imaging, non-invasive approach, precise and efficient therapeutic HIFU energy and treatment validation imaging ...
Manufactured by:Path-Tec, LLC based inMidland, GEORGIA (US) (USA)
Transport Box with Insert, (16) 10 percent NBF 20ml Vials with security seals, Biohazard Bag with Absorbent, Box ...
Manufactured by:Isotopia Molecular Imaging based inPetah Tikva, ISRAEL
Prostate cancer is one of the leading causes of morbidity and mortality in men in the western world, and the second most common cancer in men worldwide. Imaging of the prostate-specific membrane antigen (PSMA) has become an essential tool for managing patients with recurrent prostate cancer and 68Ga PSMA-11 is one of the most frequently employed ...
Manufactured by:miR Scientific, LLC based inNew York, NEW YORK (USA)
The science behind miR’s prostate and bladder cancer detection and classification technology that can help give healthcare providers, patients, and payors the greatest confidence in test results and care ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
ConfirmMDx Addresses Prostate Biopsy Sampling Error and the False-Negative Biopsy Dilemma. “Rule-in” high-risk men who have had a previous negative biopsy result, may be harboring undetected cancer (a false-negative biopsy result), and therefore may benefit from a repeat biopsy and appropriate treatment. ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures the expression of two mRNA cancer-related biomarkers (HOXC6 and DLX1).1 The test provides binary results that, when combined with the patient’s clinical risk ...
Manufactured by:Exact Imaging based inMarkham, ONTARIO (CANADA)
PRI-MUS™ (prostate risk identification using micro-ultrasound) is an evidence-based* protocol for identifying sonographic features of the prostate under micro-ultrasound to help direct and target ...
Manufactured by:EDAP TMS based inVaulx-en-Velin, FRANCE
The ExactVu™ micro-ultrasound platform provides the most practical solution as a new tool for urologists or radiologists to perform targeted biopsies within a standard urological workflow. The unique 29MHz frequency allows to visualize details unseen before in any prostate ultrasound image, detect suspicious areas in real-time and take a biopsy sample as representative of ...